Latest Breaking News On - Developing countries clinical trials partnership - Page 15 : comparemela.com

Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial

Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

South africaUnited kingdomUnited statesNew yorkGreen light committee western pacific regional officeGlobal alliance against tuberculosisTb drug developmentFast clubEuropean developing countries clinical trials partnershipGlobal allianceLondon school of hygiene tropical medicineGlobal fund to fightDepartment of foreign affairsCritical path instituteResearch future fund of the australian governmentEu innovative medicines initiative

Global award for outstanding KZN scientist

Global award for outstanding KZN scientist
iol.co.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iol.co.za Daily Mail and Mail on Sunday newspapers.

South africaEastern capeFrance generalKwazulu natalAfrica caprisaSalim abdool karimKogie naidooCollege of health sciencesTreatment research programmeUniversity of kwazuluCentre for the aids programme of researchCountries clinical trials partnershipProfessor kogie naidooOutstanding female scientist prizeDeveloping countries clinical trials partnershipSaharan africa

KUHeS seeks to establish shorter TB treatment regimen | Malawi 24

KUHeS seeks to establish shorter TB treatment regimen | Malawi 24: Stay up-to-date with the latest news from Malawi and around the world, 24/7

Hussein twabiCountries clinical trials partnershipTb research network dissemination conferenceResearch fellow at helse nord tuberculosis initiativeMedicine regulation authorityKamuzu universityHealth scienceHealth sciencesMedical doctorInfectious disease epidemiologistResearch fellowHelse nord tuberculosis initiativeInfectious disease scientistPan african consortiumAntituberculosis antibioticsDeveloping countries clinical trials partnership

WHO recommends Malaria vaccine made by Oxford University and Serum Institute of India

WHO recommends Malaria vaccine made by Oxford University and Serum Institute of India
bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.

Burkina fasoAdar poonawallaLisa stockdaleStrategic advisory group of expertsJenner institute at oxford universityMalaria policy advisory groupJenner instituteSerum institute of indiaWorld health organisationEuropean investment bankOxford universityCountries clinical trials partnershipUniversity of oxfordSerum instituteStrategic advisory groupDeveloping countries clinical trials partnership

Now We Have Two : WHO Lauds SII, Oxford for Developing Second Malaria Vaccine

WHO chief Tedros Adhanom Ghebreyesus said the world now has two vaccines to tackle the scourge of malaria.

United kingdomBurkina fasoTedros adhanom ghebreyesusAdar poonawallaStrategic advisory group of expertsMalaria policy advisory groupSerum institute of indiaUniversity of oxfordCountries clinical trials partnershipJenner institute at oxford universityEuropean investment bankWorld health organisationWorld health organizationSerum instituteStrategic advisory groupJenner institute